Detalles de la búsqueda
1.
Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.
J Mol Cell Cardiol
; 148: 1-14, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853649
2.
Limb functional recovery is impaired in fibroblast growth factor-2 (FGF2) deficient mice despite chronic ischaemia-induced vascular growth.
Growth Factors
; 38(2): 75-93, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496882
3.
Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.
J Proteome Res
; 12(10): 4268-79, 2013 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24016359
4.
Tropomyosin dephosphorylation results in compensated cardiac hypertrophy.
J Biol Chem
; 287(53): 44478-89, 2012 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23148217
5.
Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.
Am J Physiol Heart Circ Physiol
; 304(10): H1382-96, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23479264
6.
Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.
Growth Factors
; 30(2): 124-39, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22304432
7.
The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
J Mol Cell Cardiol
; 48(6): 1245-54, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20116383
8.
Kappa and delta opioid receptor signaling is augmented in the failing heart.
J Mol Cell Cardiol
; 47(4): 493-503, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19573531
9.
The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling.
Circulation
; 113(7): 995-1004, 2006 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-16476846
10.
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.
J Clin Invest
; 109(6): 787-96, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11901187
11.
Transforming growth factor beta in cardiovascular development and function.
Cytokine Growth Factor Rev
; 14(5): 391-407, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12948523
12.
A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
Cardiovasc Res
; 113(13): 1585-1602, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29016740
13.
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
Circulation
; 108(25): 3140-8, 2003 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-14656920
14.
Postnatal ablation of Foxm1 from cardiomyocytes causes late onset cardiac hypertrophy and fibrosis without exacerbating pressure overload-induced cardiac remodeling.
PLoS One
; 7(11): e48713, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23144938
15.
Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.
Mol Cell Pharmacol
; 2(4): 143-154, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21274419
16.
Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.
Am J Physiol Heart Circ Physiol
; 296(4): H967-75, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19181965
17.
Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.
Dev Dyn
; 238(2): 249-64, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18773489
18.
The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.
J Mol Cell Cardiol
; 42(1): 106-20, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17150229
19.
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2.
Am J Physiol Heart Circ Physiol
; 293(1): H354-65, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17337596
20.
Remote preconditioning-endocrine factors in organ protection against ischemic injury.
Endocr Metab Immune Disord Drug Targets
; 7(3): 167-75, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17897043